Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
The tumor microenvironment is composed of cellular and stromal components such as tumor cells, mesenchymal cells, immune cells, cancer associated fibroblasts and the supporting extracellular matrix. The tumor microenvironment provides crucial support for growth and progression of tumor cells and affects tumor response to therapeutic interventions. To better understand tumor biology and to develop effective cancer therapeutic agents it is important to develop preclinical platforms that can faithfully recapitulate the tumor microenvironment and the complex interaction between the tumor and its surrounding stromal elements. Drug studies performed in vitro with conventional two-dimensional cancer cell line models do not optimally represent clinical drug response as they lack true tumor heterogeneity and are often performed in static culture conditions lacking stromal tumor components that significantly influence the metabolic activity and proliferation of cells. Recent microfluidic approaches aim to overcome such obstacles with the use of cell lines derived in artificial three-dimensional supportive gels or micro-chambers. However, absence of a true tumor microenvironment and full interstitial flow, leads to less than optimal evaluation of tumor response to drug treatment. Here we report a continuous perfusion microfluidic device coupled with microscopy and image analysis for the assessment of drug effects on intact fresh tumor tissue. We have demonstrated that fine needle aspirate biopsies obtained from patient-derived xenograft models of adenocarcinoma of the lung can successfully be analyzed for their response to ex vivo drug treatment within this biopsy trapping microfluidic device, wherein a protein kinase C inhibitor, staurosporine, was used to assess tumor cell death as a proof of principle. This approach has the potential to study tumor tissue within its intact microenvironment to better understand tumor response to drug treatments and eventually to choose the most effective drug and drug combination for individual patients in a cost effective and timely manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due to the direct use of tumor tissue, this approach includes many key components in tumor such as heterogeneous cell types and abnormal blood vessel networks.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [165]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, the various types of cells in tumor tissues were all treated as tumor cells in these studies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [165]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687
Fabrication of novel biomaterials through molecular self-assembly
Zhang, S. (2003) · Nature Biotechnology · doi:10.1038/nbt874 · Cited by 3,347
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
El-Ali, J., Sorger, P. K., & Jensen, K. F. (2006) · Nature · doi:10.1038/nature05063 · Cited by 2,102
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Research works printed but not linked: 1
- Abdi H. The greenhouse-geisser correction. Encyclopedia of research design SAGE Publications, Thousand Oaks, CA, USA 2010.
Cited by
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
“The aim is to create an environment where different cell types can interact with each other [62].”
BackgroundMicrofluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Trujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
A multiplexed microfluidic system for evaluation of dynamics of immune–tumor interactions
Moore, N., Doty, D., Zielstorff, M., Kariv, I., Moy, L. Y., Gimbel, A., Chevillet, J. R., Lowry, N., Santos, J., Mott, V., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00256h · Cited by 104
Addressing Patient Specificity in the Engineering of Tumor Models
Bray, L. J., Hutmacher, D. W., & Bock, N. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00217 · Cited by 73
Monolithic, 3D-Printed Microfluidic Platform for Recapitulation of Dynamic Tumor Microenvironments
Beckwith, A. L., Borenstein, J. T., & Velásquez–García, L. F. (2018) · Journal of Microelectromechanical Systems · doi:10.1109/jmems.2018.2869327 · Cited by 58
“, inability to ensure development of spheroids with density and extracellular matrix composition faithful to in vivo conditions [2], and failure of cultured spheroids to reflect the heterogeneity of autochthonous tumor tissue [14].”
BackgroundMicrofluidics in Malignant Glioma Research and Precision Medicine
Logun, M. T., Zhao, W., Mao, L., & Karumbaiah, L. (2018) · Advanced Biosystems · doi:10.1002/adbi.201700221 · Cited by 48
Microfluidics for interrogating live intact tissues
Horowitz, L. F., Rodriguez, A. D., Ray, T., & Folch, A. (2020) · Microsystems & Nanoengineering · doi:10.1038/s41378-020-0164-0 · Cited by 42
Dorrigiv, D., Simeone, K., Communal, L., Kendall‐Dupont, J., St‐Georges‐Robillard, A., Péant, B., Carmona, E., Mes‐Masson, A., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164208 · Cited by 43
Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine
Mulaudzi, P. E., Abrahamse, H., & Crous, A. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10655-6 · Cited by 40
“This technique has been developed to allow for the creation of an environment in which different cell types interact with one another [116].”
MethodOrgan-on-Chip platforms to study tumor evolution and chemosensitivity
Dsouza, V. L., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188717 · Cited by 39
Hydrogels as a New Platform to Recapitulate the Tumor Microenvironment
Ermis, M., Çalamak, S., Calibasi‐Kocal, G., Güven, S., Durmus, N. G., Rizvi, I., Hasan, T. G., Hasırcı, N., Hasırcı, V., & Demirci, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813339-2.00015-3 · Cited by 39
Application of microfluidic devices for glioblastoma study: current status and future directions
Cai, X., Briggs, R. G., Homburg, H. B., Young, I. M., Davis, E. J., Lin, Y., Battiste, J. D., & Sughrue, M. E. (2020) · Biomedical Microdevices · doi:10.1007/s10544-020-00516-1 · Cited by 29
“3a) (Caballero et al. 2017; Holton et al. 2017).”
Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening
Zawawi, S. S. A., Salleh, E. A., & Musa, M. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00226 · Cited by 27
Luminescent nanomaterials for droplet tracking in a microfluidic trapping array
Vaithiyanathan, M., Bajgiran, K. R., Darapaneni, P., Safa, N., Dorman, J. A., & Melvin, A. T. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1448-1 · Cited by 23
Microfluidic technologies for ex vivo tissue biopsies: A review
Garcia-Garcia, F. C., Candarlioglu, P. L., Porter, J. D., Davies, D. E., Swindle, E. J., & Morgan, H. (2022) · Organs-on-a-Chip · doi:10.1016/j.ooc.2022.100020 · Cited by 23
Ebrahim, N. A. A., & Soliman, S. M. A. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00287-4 · Cited by 20
“Microfluidic platforms facilitate high-throughput analysis of TAFs, enabling detailed studies of their migration patterns, interactions with other cells, and responses to therapeutic agents within a simulated TME [64, 65].”
Progress and application of lung-on-a-chip for lung cancer
Li, L., Bo, W., Wang, G., Juan, X., Xue, H., & Zhang, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1378299 · Cited by 18
“This technique allows for a good representation of the spatial structure and distribution within tumour cells, which can reveal the process of proliferation, migration and invasion of tumour cells and their interactions with each other (Holton et al., 2017).”
BackgroundCancer 3D Models for Metallodrug Preclinical Testing
Engrácia, D. M., Pinto, C. I. G., & Mendes, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511915 · Cited by 12
“These microfluidic systems allow for the culture of multiple cell types, which can be separated by porous membranes or cultured in different chambers, in order to obtain a more complex tumor model where cell interactions can be recapitulated [102,103].”
BackgroundMicrofluidic systems in cancer research
Caballero, D., Luque‐González, M. A., Reis, R. L., & Kundu, S. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00015-0 · Cited by 13
Patient-Derived In Vitro and In Vivo Models of Cancer
Claridge, S. E., Cavallo, J., & Hopkins, B. D. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_12 · Cited by 11
Guzzeloni, V., Veschini, L., Pedica, F., Ferrero, E., & Ferrarini, M. (2022) · Antibodies · doi:10.3390/antib11030046 · Cited by 12
Markoski, A., Wong, I. Y., & Borenstein, J. T. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.646441 · Cited by 9
“CT26 colon cancer cells (CDL-2638), RPMI-1640 media, fetal bovine serum, and Trypsin EDTA solution 1X (30-2101) were purchased from ATCC.”
BackgroundMethodEstablishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response
Komar, Z. M., van Gent, D. C., & Chakrabarty, S. (2023) · Current Protocols · doi:10.1002/cpz1.693 · Cited by 7
Jeong, C. G., Negro, G. D., Getsios, S., & Ekert, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00005-0 · Cited by 13
Organoids for Cancer Research: Advances and Challenges
Xin, M., Li, Q., Wang, D., & Wang, Z. (2024) · Advanced Biology · doi:10.1002/adbi.202400056 · Cited by 6
Yu, Z., Khan, A. A., Naeem, W., Borgia, J. A., Liptay, M. J., Seder, C. W., & Zhou, J. (2025) · APL Bioengineering · doi:10.1063/5.0282002 · Cited by 3
“Tissue trapping chips, designed to efficiently trap individual biopsies 106 or PDOs, 57 have been developed to test chemotherapy efficacy.”
Patient-Specific Tumor Microenvironment Models
Lee, J. W., Kim, J., Shin, Y., Chi, B. H., Kim, J. H., & Choi, S. Y. (2021) · Journal of Urologic Oncology · doi:10.22465/kjuo.2021.19.4.197 · Cited by 1
“이 PDME는 처치 하지 않은 대조군에 비해 확연히 생존력이 줄었고, 약간 의 종양 내 이질성만 나타나, 임상에서 쓰게 되었을 때 더 높은 치료 성공 가능성을 보여주었다.(84) 암 세포주는 일차 종양 세포와는 다르게 화학치료제 에 반응한다고 알려져 있다.”
Hsp90: A Target for Susceptibilities and Substitutions in Biotechnological and Medicinal Application
Warnecke, A., Kirschning, A., Landsberg, D., & Zeilinger, C. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_18 · Cited by 1
Additive manufacturing of microfluidics for evaluation of immunotherapy efficacy
Beckwith, A. L. (2018) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 1
Tiwari, S. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Photoluminescent Nanomaterials for Biosensing and Single Cell Analysis Applications
Bajgiran, K. R. (2021) · Louisiana State University · doi:10.31390/gradschool_dissertations.5480
Non-Animal Technologies to Study and Target the Tumour Vasculature and Angiogenesis
Ferrero, E., Hue, J., Ferrarini, M., & Veschini, L. (2025) · Organoids · doi:10.3390/organoids4020012 · Cited by 1
Desarrollo de sistemas microfluídicos en la multiescala para el cultivo celular y tisular
Prieto, G. A. L., OCHOA GARRIDO, I., & Ledesma, L. J. F. (2018) · Zaguan (University of Zaragoza Repository) · Cited by 1
Biofabrication de modèles de cancer du sein HER2-positifs par bioimpression 3D
Simoes, M. (2024) · theses.fr (ABES) · doi:10.70675/3b76e0eczc30fz440cza3bbzfc1750a015d6
Metadata
- Authors
- Holton, A. B., Sinatra, F. L., Kreahling, J., Conway, A. J., Landis, D. A., & Altiok, S.
- Affiliations
- University of South Florida (US)
- Moffitt Cancer Center (US)
- Corresponding author
- Altiok, Soner
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-01-13
- Volume
- 12
- Issue
- 1
- Pages
- e0169797
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5235371
- OpenAlex
- W2579680847
- Cited by
- 35
- References
- 65
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 9
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Charles Stark Draper Laboratory
- H. Lee Moffitt Cancer Center and Research Institute
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor microenvironment, microfluidic perfusion, patient-derived xenografts, lung adenocarcinoma, staurosporine, PKC inhibitors, cancer cell death, tumor stroma, preclinical drug testing, precision oncology
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Antibodies, Monoclonal, Biopsy, Doxorubicin, Enzyme Inhibitors, Female, Humans, Mice, Hairless, Neoplasms, Tumor Cells, Cultured, Mice, SCID, Apoptosis, Cell Culture Techniques, Staurosporine, Xenograft Model Antitumor Assays, Microfluidic Analytical Techniques, Cell Proliferation, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.